Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | SI | P14410 | 1/20 | 0.52 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.37 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | KDM6B | O15054 | 1/20 | 0.35 |
| ▸ | KDM5C | P41229 | 1/20 | 0.35 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.35 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8804004 | 0.84 | ALDH1A1 (0.45) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL1983275 | 0.80 | MGAM (0.43) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL13478059 | 0.80 | ALDH1A1 (0.43) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL28794549 | 0.80 | MGAM (0.43) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL23408326 | 0.79 | MGAM (0.44) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL27508659 | 0.79 | ALDH1A1 (0.50) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL12533440 | 0.78 | MGAM (0.42) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL7636706 | 0.78 | ALDH1A1 (0.55) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL16634434 | 0.78 | ALDH1A1 (0.45) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL28785847 | 0.78 | MGAM (0.42) | MGAMGAASIMGAM2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116970746-A | Synthetic tanning agent containing hexabasic carbonyl and preparation method and application thereof | 南京工业大学 | 2023-10-31 | — | — | CN | claimed |
| CN-116356085-A | Aliphatic synthetic tanning agent containing hexabasic carbonyl and preparation method and application thereof | 南京工业大学 | 2023-06-30 | — | — | CN | claimed |
| CN-116334320-A | Aliphatic synthetic tanning agent containing multifunctional groups and preparation method and application thereof | 南京工业大学 | 2023-06-27 | — | — | CN | claimed |
| CN-116219085-A | Synthetic tanning agent containing multifunctional structure and preparation method and application thereof | 南京工业大学 | 2023-06-06 | — | — | CN | claimed |
| US-12378234-B2 | Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative | BANTAM PHARMACEUTICAL, LLC (US) | 2025-08-05 | — | — | US | disclosed |
| US-12251372-B2 | Antileishmanial compounds, compositions and use thereof | TRUSTEES OF BOSTON UNIVERSITY | 2025-03-18 | — | — | US | disclosed |
| CN-118638119-B | Pyrazole purine herbicide safener as well as preparation method and application thereof | 东北农业大学 | 2025-02-28 | — | — | CN | disclosed |
| US-12150934-B2 | Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases | BANTAM PHARMACEUTICAL, LLC (US) | 2024-11-26 | — | — | US | disclosed |
| CN-118638119-A | Pyrazole purine herbicide safener as well as preparation method and application thereof | 东北农业大学 | 2024-09-13 | — | — | CN | disclosed |
| CN-116356085-B | Aliphatic synthetic tanning agent containing hexabasic carbonyl and preparation method and application thereof | 南京工业大学 | 2024-08-16 | — | — | CN | disclosed |
| US-20240240077-A1 | COLOR CONVERSION COMPOSITION, COLOR CONVERSION FILM, LIGHT SOURCE UNIT, DISPLAY, AND LIGHTING INCLUDING SAME, AND COMPOUND | TORAY INDUSTRIES, INC. (JP) | 2024-07-18 | — | — | US | disclosed |
| CN-116219085-B | Synthetic tanning agent containing multifunctional structure and preparation method and application thereof | 南京工业大学 | 2024-03-15 | — | — | CN | disclosed |
| EP-0915700-A1 | USE OF BETA-SHEET MIMETICS AS PROTEASE AND KINASE INHIBITORS AND AS INHIBITORS OF TRANSCRIPTION FACTORS | MOLECUMETICS, LTD. (US) | 1999-05-19 | — | — | EP | disclosed |
| US-5859007-A | TREATMENT OF DIABETES, OBESITY | GLAXO WELLCOME INC. (US) | 1999-01-12 | — | — | US | disclosed |
| WO-1998054246-A1 | β-KETOESTERS FOR USE AS POLYMER STABILISERS | AKCROS CHEMICALS (GB) | 1998-12-03 | — | — | WO | disclosed |
| EP-0881253-A1 | B-ketoesters for use as polymer stabilisers | AKCROS CHEMICALS (GB) | 1998-12-02 | — | — | EP | disclosed |
| WO-1998005333-A1 | USE OF BETA-SHEET MIMETICS AS PROTEASE AND KINASE INHIBITORS AND AS INHIBITORS OF TRANSCRIPTION FACTORS | MOLECUMETICS LTD. (US) | 1998-02-12 | — | — | WO | disclosed |
| EP-0755384-A1 | CCK OR GASTRIN MODULATING 1,5 BENZODIAZEPINES DERIVATIVES | GLAXO WELLCOME INC. (US) | 1997-01-29 | — | — | EP | disclosed |
| WO-1995028391-A1 | CCK OR GASTRIN MODULATING 1,5 BENZODIAZEPINES DERIVATIVES | GLAXO WELLCOME INC. (US) | 1995-10-26 | — | — | WO | disclosed |
| EP-0372470-A2 | Novel alpha-cyano-beta-oxopropionamides | CIBA-GEIGY AG (CH) | 1990-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240240077-A1 | COLOR CONVERSION COMPOSITION, COLOR CONVERSION FILM, LIGHT SOURCE UNIT, DISPLAY, AND LIGHTING INCLUDING SAME, AND COMPOUND | CDYL, ZKSCAN2, CAD | MGAM 518/4885GAA 659/4885SI 2915/4885 |
| US-12251372-B2 | Antileishmanial compounds, compositions and use thereof | MPO, SSB, SGMS2 | MGAM 99/4885GAA 111/4885SI 1705/4885 |
| US-12150934-B2 | Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases | KRAS, TP53, CCNA1 | MGAM 4592/4885GAA 2623/4885SI 3557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.